Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
2M
-
Shares change
-
+655K
-
Total reported value, excl. options
-
$5.18M
-
Value change
-
+$1.67M
-
Number of buys
-
16
-
Number of sells
-
-7
-
Price
-
$2.61
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q3 2020
37 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q3 2020.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2M shares
of 41M outstanding shares and own 4.88% of the company stock.
Largest 10 shareholders include MORGAN JESS S & CO INC (576K shares), RENAISSANCE TECHNOLOGIES LLC (469K shares), Phoenix Holdings Ltd. (198K shares), ETF MANAGERS GROUP, LLC (98.5K shares), BlackRock Inc. (89K shares), Qube Research & Technologies Ltd (75.4K shares), Frontier Wealth Management LLC (71.9K shares), MILLENNIUM MANAGEMENT LLC (70.1K shares), MARSHALL WACE, LLP (58.6K shares), and LMR Partners LLP (33K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.